tiprankstipranks
Trending News
More News >
Novavax (NVAX)
NASDAQ:NVAX

Novavax (NVAX) Stock Statistics & Valuation Metrics

Compare
9,881 Followers

Total Valuation

Novavax has a market cap or net worth of $1.20B. The enterprise value is ―.
Market Cap$1.20B
Enterprise Value

Share Statistics

Novavax has 161,970,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding161,970,340
Owned by Insiders0.39%
Owned by Institutions21.00%

Financial Efficiency

Novavax’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is -63.99%.
Return on Equity (ROE)0.30
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-63.99%
Return on Capital Employed (ROCE)-0.61
Revenue Per Employee716.56K
Profits Per Employee-196.95K
Employee Count952
Asset Turnover0.44
Inventory Turnover23.17

Valuation Ratios

The current PE Ratio of Novavax is -6.53. Novavax’s PEG ratio is -0.14.
PE Ratio-6.53
PS Ratio0.00
PB Ratio-1.80
Price to Fair Value-1.96
Price to FCF-11.19
Price to Operating Cash Flow-12.85
PEG Ratio-0.14

Income Statement

In the last 12 months, Novavax had revenue of 682.16M and earned -187.50M in profits. Earnings per share was -1.23.
Revenue682.16M
Gross Profit479.42M
Operating Income-248.93M
Pretax Income-176.62M
Net Income-187.50M
EBITDA-108.04M
Earnings Per Share (EPS)-1.23

Cash Flow

In the last 12 months, operating cash flow was -87.26M and capital expenditures -13.38M, giving a free cash flow of -100.64M billion.
Operating Cash Flow-87.26M
Free Cash Flow-100.64M
Free Cash Flow per Share-0.62

Dividends & Yields

Novavax pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.60
52-Week Price Change-54.20%
50-Day Moving Average6.68
200-Day Moving Average9.10
Relative Strength Index (RSI)51.40
Average Volume (3m)11.25M

Important Dates

Novavax upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date

Financial Position

Novavax as a current ratio of 0.98, with Debt / Equity ratio of -36.94%
Current Ratio0.98
Quick Ratio0.97
Debt to Market Cap0.19
Net Debt to EBITDA2.77
Interest Coverage Ratio-12.40

Taxes

In the past 12 months, Novavax has paid 10.88M in taxes.
Income Tax10.88M
Effective Tax Rate-0.06

Enterprise Valuation

Novavax EV to EBITDA ratio is -8.55, with an EV/FCF ratio of -9.21.
EV to Sales1.35
EV to EBITDA-8.55
EV to Free Cash Flow-9.21
EV to Operating Cash Flow-10.59

Balance Sheet

Novavax has $923.12M in cash and marketable securities with $230.42M in debt, giving a net cash position of -$692.70M billion.
Cash & Marketable Securities$923.12M
Total Debt$230.42M
Net Cash-$692.70M
Net Cash Per Share-$4.28
Tangible Book Value Per Share-$4.81

Margins

Gross margin is 73.30%, with operating margin of -36.49%, and net profit margin of -27.49%.
Gross Margin73.30%
Operating Margin-36.49%
Pretax Margin-25.89%
Net Profit Margin-27.49%
EBITDA Margin-15.84%
EBIT Margin-22.95%

Analyst Forecast

The average price target for Novavax is $11.25, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$11.25
Price Target Upside62.57% Upside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast25.92%
EPS Growth Forecast

Scores

Smart Score9
AI Score64
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis